anti human tlr2 Search Results


95
Miltenyi Biotec fluorescence labeled antibody
Fluorescence Labeled Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluorescence labeled antibody/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
fluorescence labeled antibody - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Miltenyi Biotec reafinity
Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/reafinity/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
reafinity - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Miltenyi Biotec cd282 tlr2 apc
Cd282 Tlr2 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd282 tlr2 apc/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
cd282 tlr2 apc - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Miltenyi Biotec tlr2 pe vio615
Tlr2 Pe Vio615, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tlr2 pe vio615/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
tlr2 pe vio615 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Miltenyi Biotec tlr2 pe vio770
Co-stimulation with TLR1/2, <t>TLR2/6,</t> and TLR5 agonists enhances the proliferative response of human blood-derived CD8 + T cells to TCR triggering. (A) Expression profiles of surface TLRs in resting CD8 + T cells within human blood mononuclear cells (PBMCs). The T cell subpopulations of human PBMCs were identified by staining the cells with antibodies against CD3, CD4, and CD8; the TLR expression was measured by flow cytometry and expressed as the percentage of positively stained cells. Shown is aggregated data of 12 samples. (B and C) Co-stimulatory effects of different TLR agonists on the proliferation of human PBMC-derived CD8 + T cells. CD8+T cells were purified from human PBMCs, stained with eFluor 670, and then stimulated with ant-CD3 beads, anti-CD3/CD28 beads, or anti-CD3 beads coupled with the indicated TLRs agonists. Cells were harvested 7 days later and dilution of eFluor 670 was determined by flow cytometry to measure cellular proliferation, with representative flow cytometry plot and data summary (n = 3) shown in (B) and (C) , respectively. (D,E) Determination of optimal dosages of TLR agonists required for co-stimulation of ex vivo proliferation of human CD8 + T cells. CD8+T cells purified from human PBMCs were stimulated with anti-CD3 beads in presence of various concentration of TLR1/2 agonist, <t>TLR2/6</t> agonist, or TLR5 agonist after labelling with eFluor 670. Flow cytometry analyses were performed on day 4 and 6 after stimulation to determine the cellular proliferation through assessment of eFluor 670 dilution. Shown is aggregated data of 3 samples.
Tlr2 Pe Vio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tlr2 pe vio770/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
tlr2 pe vio770 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

92
fluidigm in house cd282 tlr2 tl2 1 176yb fluidigm
Co-stimulation with TLR1/2, <t>TLR2/6,</t> and TLR5 agonists enhances the proliferative response of human blood-derived CD8 + T cells to TCR triggering. (A) Expression profiles of surface TLRs in resting CD8 + T cells within human blood mononuclear cells (PBMCs). The T cell subpopulations of human PBMCs were identified by staining the cells with antibodies against CD3, CD4, and CD8; the TLR expression was measured by flow cytometry and expressed as the percentage of positively stained cells. Shown is aggregated data of 12 samples. (B and C) Co-stimulatory effects of different TLR agonists on the proliferation of human PBMC-derived CD8 + T cells. CD8+T cells were purified from human PBMCs, stained with eFluor 670, and then stimulated with ant-CD3 beads, anti-CD3/CD28 beads, or anti-CD3 beads coupled with the indicated TLRs agonists. Cells were harvested 7 days later and dilution of eFluor 670 was determined by flow cytometry to measure cellular proliferation, with representative flow cytometry plot and data summary (n = 3) shown in (B) and (C) , respectively. (D,E) Determination of optimal dosages of TLR agonists required for co-stimulation of ex vivo proliferation of human CD8 + T cells. CD8+T cells purified from human PBMCs were stimulated with anti-CD3 beads in presence of various concentration of TLR1/2 agonist, <t>TLR2/6</t> agonist, or TLR5 agonist after labelling with eFluor 670. Flow cytometry analyses were performed on day 4 and 6 after stimulation to determine the cellular proliferation through assessment of eFluor 670 dilution. Shown is aggregated data of 3 samples.
In House Cd282 Tlr2 Tl2 1 176yb Fluidigm, supplied by fluidigm, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/in house cd282 tlr2 tl2 1 176yb fluidigm/product/fluidigm
Average 92 stars, based on 1 article reviews
in house cd282 tlr2 tl2 1 176yb fluidigm - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

90
Rockland Immunochemicals tlr2 antibody
Baseline characteristics and comparison stratified by Toll-like receptor <t> (TLR) 2 </t> cytoplasmic intensity in primary tumors and lymph node metastases.
Tlr2 Antibody, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tlr2 antibody/product/Rockland Immunochemicals
Average 90 stars, based on 1 article reviews
tlr2 antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
ImmunoKontact anti-human tlr2 neutralizing antibodies
HSV and PAMPs induce IFN, ISGs, and proinflammatory cytokines in human primary macrophages. (A to C and G) Macrophages were infected with HSV-1 (17+, 5 × 105 PFU/ml, MOI of 1) or transfected with poly(I:C) [t-poly(I:C); 2 μg/ml] or poly(dA:dT) [t-poly(dA:dT); 2 μg/ml]. (A to C and G) After 6 h, after which RNA was harvested and mRNA accumulation of IFN-β, IFN-λ1, CXCL10, and TNF-α was assayed by real-time PCR. (D, E, and H) In similar experiments, cell supernatants were harvested after 20 h and assayed for the presence of TNF-α, CXCL10, and CCL3 by ELISA. (E, F, I, and K) Macrophages were infected with HSV or stimulated with IFN-α (100 IU/ml) or the agonist for <t>TLR2</t> (Pam3CSK4, 100 ng/ml), TLR3 [poly(I:C), 30 μg/ml], TLR7/8 (R848, 1 μg/ml), or TLR9 (ODN2216, 2 μg/ml). After 20 h of stimulation, supernatants were collected and protein levels assayed by ELISA. (J and L) Cells were infected with HSV-1 (17+ or KOS, 5 × 105 PFU/ml, MOI of 1) or HSV-2 (MOI of 1). Supernatants were harvested at 18 h and assayed by ELISA for CXCL10 and CCL3. The real-time PCR data are depicted as relative units (RU), which is a fold change in gene expression normalized to that of the endogenous reference gene 18S rRNA and is relative to the no template control (NTC) calibrator. The results depicted are means ± standard deviations (SD) within the shown experiment. Experiments were done five times (A and B) or two times (C to L), with similar findings.
Anti Human Tlr2 Neutralizing Antibodies, supplied by ImmunoKontact, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-human tlr2 neutralizing antibodies/product/ImmunoKontact
Average 90 stars, based on 1 article reviews
anti-human tlr2 neutralizing antibodies - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Innovagen AB anti-tlr2 antibody
HSV and PAMPs induce IFN, ISGs, and proinflammatory cytokines in human primary macrophages. (A to C and G) Macrophages were infected with HSV-1 (17+, 5 × 105 PFU/ml, MOI of 1) or transfected with poly(I:C) [t-poly(I:C); 2 μg/ml] or poly(dA:dT) [t-poly(dA:dT); 2 μg/ml]. (A to C and G) After 6 h, after which RNA was harvested and mRNA accumulation of IFN-β, IFN-λ1, CXCL10, and TNF-α was assayed by real-time PCR. (D, E, and H) In similar experiments, cell supernatants were harvested after 20 h and assayed for the presence of TNF-α, CXCL10, and CCL3 by ELISA. (E, F, I, and K) Macrophages were infected with HSV or stimulated with IFN-α (100 IU/ml) or the agonist for <t>TLR2</t> (Pam3CSK4, 100 ng/ml), TLR3 [poly(I:C), 30 μg/ml], TLR7/8 (R848, 1 μg/ml), or TLR9 (ODN2216, 2 μg/ml). After 20 h of stimulation, supernatants were collected and protein levels assayed by ELISA. (J and L) Cells were infected with HSV-1 (17+ or KOS, 5 × 105 PFU/ml, MOI of 1) or HSV-2 (MOI of 1). Supernatants were harvested at 18 h and assayed by ELISA for CXCL10 and CCL3. The real-time PCR data are depicted as relative units (RU), which is a fold change in gene expression normalized to that of the endogenous reference gene 18S rRNA and is relative to the no template control (NTC) calibrator. The results depicted are means ± standard deviations (SD) within the shown experiment. Experiments were done five times (A and B) or two times (C to L), with similar findings.
Anti Tlr2 Antibody, supplied by Innovagen AB, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-tlr2 antibody/product/Innovagen AB
Average 90 stars, based on 1 article reviews
anti-tlr2 antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Cascade BioScience blocking anti-human tlr2 monoclonal antibodies
HSV and PAMPs induce IFN, ISGs, and proinflammatory cytokines in human primary macrophages. (A to C and G) Macrophages were infected with HSV-1 (17+, 5 × 105 PFU/ml, MOI of 1) or transfected with poly(I:C) [t-poly(I:C); 2 μg/ml] or poly(dA:dT) [t-poly(dA:dT); 2 μg/ml]. (A to C and G) After 6 h, after which RNA was harvested and mRNA accumulation of IFN-β, IFN-λ1, CXCL10, and TNF-α was assayed by real-time PCR. (D, E, and H) In similar experiments, cell supernatants were harvested after 20 h and assayed for the presence of TNF-α, CXCL10, and CCL3 by ELISA. (E, F, I, and K) Macrophages were infected with HSV or stimulated with IFN-α (100 IU/ml) or the agonist for <t>TLR2</t> (Pam3CSK4, 100 ng/ml), TLR3 [poly(I:C), 30 μg/ml], TLR7/8 (R848, 1 μg/ml), or TLR9 (ODN2216, 2 μg/ml). After 20 h of stimulation, supernatants were collected and protein levels assayed by ELISA. (J and L) Cells were infected with HSV-1 (17+ or KOS, 5 × 105 PFU/ml, MOI of 1) or HSV-2 (MOI of 1). Supernatants were harvested at 18 h and assayed by ELISA for CXCL10 and CCL3. The real-time PCR data are depicted as relative units (RU), which is a fold change in gene expression normalized to that of the endogenous reference gene 18S rRNA and is relative to the no template control (NTC) calibrator. The results depicted are means ± standard deviations (SD) within the shown experiment. Experiments were done five times (A and B) or two times (C to L), with similar findings.
Blocking Anti Human Tlr2 Monoclonal Antibodies, supplied by Cascade BioScience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/blocking anti-human tlr2 monoclonal antibodies/product/Cascade BioScience
Average 90 stars, based on 1 article reviews
blocking anti-human tlr2 monoclonal antibodies - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Autogen-Bioclear ltd polyclonal goat anti-human tlr2
HSV and PAMPs induce IFN, ISGs, and proinflammatory cytokines in human primary macrophages. (A to C and G) Macrophages were infected with HSV-1 (17+, 5 × 105 PFU/ml, MOI of 1) or transfected with poly(I:C) [t-poly(I:C); 2 μg/ml] or poly(dA:dT) [t-poly(dA:dT); 2 μg/ml]. (A to C and G) After 6 h, after which RNA was harvested and mRNA accumulation of IFN-β, IFN-λ1, CXCL10, and TNF-α was assayed by real-time PCR. (D, E, and H) In similar experiments, cell supernatants were harvested after 20 h and assayed for the presence of TNF-α, CXCL10, and CCL3 by ELISA. (E, F, I, and K) Macrophages were infected with HSV or stimulated with IFN-α (100 IU/ml) or the agonist for <t>TLR2</t> (Pam3CSK4, 100 ng/ml), TLR3 [poly(I:C), 30 μg/ml], TLR7/8 (R848, 1 μg/ml), or TLR9 (ODN2216, 2 μg/ml). After 20 h of stimulation, supernatants were collected and protein levels assayed by ELISA. (J and L) Cells were infected with HSV-1 (17+ or KOS, 5 × 105 PFU/ml, MOI of 1) or HSV-2 (MOI of 1). Supernatants were harvested at 18 h and assayed by ELISA for CXCL10 and CCL3. The real-time PCR data are depicted as relative units (RU), which is a fold change in gene expression normalized to that of the endogenous reference gene 18S rRNA and is relative to the no template control (NTC) calibrator. The results depicted are means ± standard deviations (SD) within the shown experiment. Experiments were done five times (A and B) or two times (C to L), with similar findings.
Polyclonal Goat Anti Human Tlr2, supplied by Autogen-Bioclear ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal goat anti-human tlr2/product/Autogen-Bioclear ltd
Average 90 stars, based on 1 article reviews
polyclonal goat anti-human tlr2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Regeneron inc anti-human tlr2 antibody
HSV and PAMPs induce IFN, ISGs, and proinflammatory cytokines in human primary macrophages. (A to C and G) Macrophages were infected with HSV-1 (17+, 5 × 105 PFU/ml, MOI of 1) or transfected with poly(I:C) [t-poly(I:C); 2 μg/ml] or poly(dA:dT) [t-poly(dA:dT); 2 μg/ml]. (A to C and G) After 6 h, after which RNA was harvested and mRNA accumulation of IFN-β, IFN-λ1, CXCL10, and TNF-α was assayed by real-time PCR. (D, E, and H) In similar experiments, cell supernatants were harvested after 20 h and assayed for the presence of TNF-α, CXCL10, and CCL3 by ELISA. (E, F, I, and K) Macrophages were infected with HSV or stimulated with IFN-α (100 IU/ml) or the agonist for <t>TLR2</t> (Pam3CSK4, 100 ng/ml), TLR3 [poly(I:C), 30 μg/ml], TLR7/8 (R848, 1 μg/ml), or TLR9 (ODN2216, 2 μg/ml). After 20 h of stimulation, supernatants were collected and protein levels assayed by ELISA. (J and L) Cells were infected with HSV-1 (17+ or KOS, 5 × 105 PFU/ml, MOI of 1) or HSV-2 (MOI of 1). Supernatants were harvested at 18 h and assayed by ELISA for CXCL10 and CCL3. The real-time PCR data are depicted as relative units (RU), which is a fold change in gene expression normalized to that of the endogenous reference gene 18S rRNA and is relative to the no template control (NTC) calibrator. The results depicted are means ± standard deviations (SD) within the shown experiment. Experiments were done five times (A and B) or two times (C to L), with similar findings.
Anti Human Tlr2 Antibody, supplied by Regeneron inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-human tlr2 antibody/product/Regeneron inc
Average 90 stars, based on 1 article reviews
anti-human tlr2 antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Co-stimulation with TLR1/2, TLR2/6, and TLR5 agonists enhances the proliferative response of human blood-derived CD8 + T cells to TCR triggering. (A) Expression profiles of surface TLRs in resting CD8 + T cells within human blood mononuclear cells (PBMCs). The T cell subpopulations of human PBMCs were identified by staining the cells with antibodies against CD3, CD4, and CD8; the TLR expression was measured by flow cytometry and expressed as the percentage of positively stained cells. Shown is aggregated data of 12 samples. (B and C) Co-stimulatory effects of different TLR agonists on the proliferation of human PBMC-derived CD8 + T cells. CD8+T cells were purified from human PBMCs, stained with eFluor 670, and then stimulated with ant-CD3 beads, anti-CD3/CD28 beads, or anti-CD3 beads coupled with the indicated TLRs agonists. Cells were harvested 7 days later and dilution of eFluor 670 was determined by flow cytometry to measure cellular proliferation, with representative flow cytometry plot and data summary (n = 3) shown in (B) and (C) , respectively. (D,E) Determination of optimal dosages of TLR agonists required for co-stimulation of ex vivo proliferation of human CD8 + T cells. CD8+T cells purified from human PBMCs were stimulated with anti-CD3 beads in presence of various concentration of TLR1/2 agonist, TLR2/6 agonist, or TLR5 agonist after labelling with eFluor 670. Flow cytometry analyses were performed on day 4 and 6 after stimulation to determine the cellular proliferation through assessment of eFluor 670 dilution. Shown is aggregated data of 3 samples.

Journal: Frontiers in Bioengineering and Biotechnology

Article Title: Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors

doi: 10.3389/fbioe.2022.1027619

Figure Lengend Snippet: Co-stimulation with TLR1/2, TLR2/6, and TLR5 agonists enhances the proliferative response of human blood-derived CD8 + T cells to TCR triggering. (A) Expression profiles of surface TLRs in resting CD8 + T cells within human blood mononuclear cells (PBMCs). The T cell subpopulations of human PBMCs were identified by staining the cells with antibodies against CD3, CD4, and CD8; the TLR expression was measured by flow cytometry and expressed as the percentage of positively stained cells. Shown is aggregated data of 12 samples. (B and C) Co-stimulatory effects of different TLR agonists on the proliferation of human PBMC-derived CD8 + T cells. CD8+T cells were purified from human PBMCs, stained with eFluor 670, and then stimulated with ant-CD3 beads, anti-CD3/CD28 beads, or anti-CD3 beads coupled with the indicated TLRs agonists. Cells were harvested 7 days later and dilution of eFluor 670 was determined by flow cytometry to measure cellular proliferation, with representative flow cytometry plot and data summary (n = 3) shown in (B) and (C) , respectively. (D,E) Determination of optimal dosages of TLR agonists required for co-stimulation of ex vivo proliferation of human CD8 + T cells. CD8+T cells purified from human PBMCs were stimulated with anti-CD3 beads in presence of various concentration of TLR1/2 agonist, TLR2/6 agonist, or TLR5 agonist after labelling with eFluor 670. Flow cytometry analyses were performed on day 4 and 6 after stimulation to determine the cellular proliferation through assessment of eFluor 670 dilution. Shown is aggregated data of 3 samples.

Article Snippet: For surface staining, cells were stained in FACS buffer (PBS supplemented with 2% bovine serum albumin) sequentially with a fixable viability dye and a combination of the following antibodies: CD3-ECD (IM2705U, Beckman coulter), CD8-BV711(563677, BD Pharmingen), CD4-percp-cy5.5 (300530, Biolegend), CD14-BV786(563699, BD Pharmingen), TLR1-FITC(sc-47709FITC, Santa Cruz), TLR2-PE-Vio770 (130-099-021, Miltenyi), TLR4-BV421 (312811, Biolegend), TLR5-Alexa Fluor 700 (NBP2-24787AF700, NOVUS biology), TLR6-DyLight 350 (NB100-56536UV, NOVUS biology), CD3-BV421(562426, BD Pharmingen), CD8-APC-H7(580179, BD Pharmingen), PD-1-PE-CF594(565024, BD Pharmingen), CTLA-4-APC(555855, BD Pharmingen), ICOS-FITC(313505, Biolegend), 4-1BB-PE-Cy7 (309818, Biolegend).

Techniques: Derivative Assay, Expressing, Staining, Flow Cytometry, Purification, Ex Vivo, Concentration Assay

Co-stimulation with a combination of TLR1/2, TLR2/6, and TLR5 agonists enhances the transcriptional induction of proliferative-related genes in human blood-derived CD8 + T cells responding to TCR triggering. CD8+T cells purified from human PBMCs were stimulated with anti-CD3 beads in the presence or absence of a combination of TLR1/2 agonist, TLR2/6 agonist, and TLR5 agonist. Cells were harvested 24 h later for extracting total RNA, which was subjected to RNA sequencing. The differentially expressed genes showing >2-fold change between minus and plus TLR agonists groups were clustered based on Gene Ontology (GO) enrichment analysis (A) . Shown in (B) is the heatmap of representative proliferation-related genes that were identified to be co-stimulated by TLR agonists. H1 to H3 represent samples from three healthy individuals.

Journal: Frontiers in Bioengineering and Biotechnology

Article Title: Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors

doi: 10.3389/fbioe.2022.1027619

Figure Lengend Snippet: Co-stimulation with a combination of TLR1/2, TLR2/6, and TLR5 agonists enhances the transcriptional induction of proliferative-related genes in human blood-derived CD8 + T cells responding to TCR triggering. CD8+T cells purified from human PBMCs were stimulated with anti-CD3 beads in the presence or absence of a combination of TLR1/2 agonist, TLR2/6 agonist, and TLR5 agonist. Cells were harvested 24 h later for extracting total RNA, which was subjected to RNA sequencing. The differentially expressed genes showing >2-fold change between minus and plus TLR agonists groups were clustered based on Gene Ontology (GO) enrichment analysis (A) . Shown in (B) is the heatmap of representative proliferation-related genes that were identified to be co-stimulated by TLR agonists. H1 to H3 represent samples from three healthy individuals.

Article Snippet: For surface staining, cells were stained in FACS buffer (PBS supplemented with 2% bovine serum albumin) sequentially with a fixable viability dye and a combination of the following antibodies: CD3-ECD (IM2705U, Beckman coulter), CD8-BV711(563677, BD Pharmingen), CD4-percp-cy5.5 (300530, Biolegend), CD14-BV786(563699, BD Pharmingen), TLR1-FITC(sc-47709FITC, Santa Cruz), TLR2-PE-Vio770 (130-099-021, Miltenyi), TLR4-BV421 (312811, Biolegend), TLR5-Alexa Fluor 700 (NBP2-24787AF700, NOVUS biology), TLR6-DyLight 350 (NB100-56536UV, NOVUS biology), CD3-BV421(562426, BD Pharmingen), CD8-APC-H7(580179, BD Pharmingen), PD-1-PE-CF594(565024, BD Pharmingen), CTLA-4-APC(555855, BD Pharmingen), ICOS-FITC(313505, Biolegend), 4-1BB-PE-Cy7 (309818, Biolegend).

Techniques: Derivative Assay, Purification, RNA Sequencing

TLR agonists is an advantageous supplement benefiting the ex vivo expansion of human blood-derived PD1+ CD8 + T cells. (A) Exploration of optimal combination of TLR agonists in facilitating the ex vivo expansion of human blood-derived PD1+ CD8 + T cells. PD1+ CD8 + T cells isolated from blood samples of health individuals were continuously cultured for 21 days in medium containing anti-CD3/anti-CD28 beads and IL-7/IL-15, either alone or in the presence of different combination of TLR1/2, TLR2/6, and TLR5 agonists. Cell counting was performed at various time points throughout the culture period to generate the cell expansion curve. (B) Expansion curves of PD1+ CD8 + T cells derived from blood samples of cancer patients with different tumor types. Among the total of fifteen samples, seven were with lung cancer, four with pancreatic cancer, and the rest four with other types of cancers. Five samples from healthy individuals were also included as controls.

Journal: Frontiers in Bioengineering and Biotechnology

Article Title: Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors

doi: 10.3389/fbioe.2022.1027619

Figure Lengend Snippet: TLR agonists is an advantageous supplement benefiting the ex vivo expansion of human blood-derived PD1+ CD8 + T cells. (A) Exploration of optimal combination of TLR agonists in facilitating the ex vivo expansion of human blood-derived PD1+ CD8 + T cells. PD1+ CD8 + T cells isolated from blood samples of health individuals were continuously cultured for 21 days in medium containing anti-CD3/anti-CD28 beads and IL-7/IL-15, either alone or in the presence of different combination of TLR1/2, TLR2/6, and TLR5 agonists. Cell counting was performed at various time points throughout the culture period to generate the cell expansion curve. (B) Expansion curves of PD1+ CD8 + T cells derived from blood samples of cancer patients with different tumor types. Among the total of fifteen samples, seven were with lung cancer, four with pancreatic cancer, and the rest four with other types of cancers. Five samples from healthy individuals were also included as controls.

Article Snippet: For surface staining, cells were stained in FACS buffer (PBS supplemented with 2% bovine serum albumin) sequentially with a fixable viability dye and a combination of the following antibodies: CD3-ECD (IM2705U, Beckman coulter), CD8-BV711(563677, BD Pharmingen), CD4-percp-cy5.5 (300530, Biolegend), CD14-BV786(563699, BD Pharmingen), TLR1-FITC(sc-47709FITC, Santa Cruz), TLR2-PE-Vio770 (130-099-021, Miltenyi), TLR4-BV421 (312811, Biolegend), TLR5-Alexa Fluor 700 (NBP2-24787AF700, NOVUS biology), TLR6-DyLight 350 (NB100-56536UV, NOVUS biology), CD3-BV421(562426, BD Pharmingen), CD8-APC-H7(580179, BD Pharmingen), PD-1-PE-CF594(565024, BD Pharmingen), CTLA-4-APC(555855, BD Pharmingen), ICOS-FITC(313505, Biolegend), 4-1BB-PE-Cy7 (309818, Biolegend).

Techniques: Ex Vivo, Derivative Assay, Isolation, Cell Culture, Cell Counting

Baseline characteristics and comparison stratified by Toll-like receptor  (TLR) 2  cytoplasmic intensity in primary tumors and lymph node metastases.

Journal: PLOS ONE

Article Title: Toll-like receptors 1–9 in small bowel neuroendocrine tumors–Clinical significance and prognosis

doi: 10.1371/journal.pone.0302813

Figure Lengend Snippet: Baseline characteristics and comparison stratified by Toll-like receptor (TLR) 2 cytoplasmic intensity in primary tumors and lymph node metastases.

Article Snippet: After this, sections were incubated with rabbit polyclonal antibodies (TLRs 1, 2, 6, 7) and mouse monoclonal antibodies (TLRs 3, 4, 5, 8, 9) in dilute solution (Dako S2022); TLR1 for 60 minutes (diluted 1:300, Abcam ab189337), TLR2 for 60 minutes (diluted 1:500, Rockland 600-401-956), TLR3 for 120 minutes (diluted 1:30, Novus NBP2-24875), TLR4 for 60 minutes (diluted 1:1000, Abnova H00007099-M02), TLR5 for overnight in +4°C (diluted 1:75, Novus NBP2-24787), TLR6 for 60 minutes (diluted 1:750, Abnova PAB 3555), TLR7 for 60 minutes (diluted 1:500, Novus NB100-56682), TLR8 for 60 minutes (diluted 1:850, Novus NBP2-24917) and TLR9 for 60 minutes (diluted 1:300, Novus NBP2-24729).

Techniques: Comparison

Immunohistochemical staining examples of Toll-like receptors (TLRs) 1, 2, 4, 5, 6, 7, 8 and 9 in representative small bowel neuroendocrine tumor samples showing ( A ) High TLR1 cytoplasmic intensity, ( B ) intermediate TLR2 cytoplasmic intensity, ( C ) intermediate TLR4 cytoplasmic intensity, ( D ) high TLR5 cytoplasmic and nucleic intensity, ( E ) Intermediate TLR6 cytoplasmic intensity, ( F ) intermediate TLR7 cytoplasmic intensity, ( G ) high TLR8 cytoplasmic intensity and ( H ) intermediate TLR9 cytoplasmic intensity in x20 magnification. The scale bar length is 50 μm (bottom left corner). Arrows indicate TLR-positive tumor cell islets.

Journal: PLOS ONE

Article Title: Toll-like receptors 1–9 in small bowel neuroendocrine tumors–Clinical significance and prognosis

doi: 10.1371/journal.pone.0302813

Figure Lengend Snippet: Immunohistochemical staining examples of Toll-like receptors (TLRs) 1, 2, 4, 5, 6, 7, 8 and 9 in representative small bowel neuroendocrine tumor samples showing ( A ) High TLR1 cytoplasmic intensity, ( B ) intermediate TLR2 cytoplasmic intensity, ( C ) intermediate TLR4 cytoplasmic intensity, ( D ) high TLR5 cytoplasmic and nucleic intensity, ( E ) Intermediate TLR6 cytoplasmic intensity, ( F ) intermediate TLR7 cytoplasmic intensity, ( G ) high TLR8 cytoplasmic intensity and ( H ) intermediate TLR9 cytoplasmic intensity in x20 magnification. The scale bar length is 50 μm (bottom left corner). Arrows indicate TLR-positive tumor cell islets.

Article Snippet: After this, sections were incubated with rabbit polyclonal antibodies (TLRs 1, 2, 6, 7) and mouse monoclonal antibodies (TLRs 3, 4, 5, 8, 9) in dilute solution (Dako S2022); TLR1 for 60 minutes (diluted 1:300, Abcam ab189337), TLR2 for 60 minutes (diluted 1:500, Rockland 600-401-956), TLR3 for 120 minutes (diluted 1:30, Novus NBP2-24875), TLR4 for 60 minutes (diluted 1:1000, Abnova H00007099-M02), TLR5 for overnight in +4°C (diluted 1:75, Novus NBP2-24787), TLR6 for 60 minutes (diluted 1:750, Abnova PAB 3555), TLR7 for 60 minutes (diluted 1:500, Novus NB100-56682), TLR8 for 60 minutes (diluted 1:850, Novus NBP2-24917) and TLR9 for 60 minutes (diluted 1:300, Novus NBP2-24729).

Techniques: Immunohistochemical staining, Staining

Median Toll-like receptor (TLR) staining intensity in primary small bowel neuroendocrine tumors and lymph node metastases.

Journal: PLOS ONE

Article Title: Toll-like receptors 1–9 in small bowel neuroendocrine tumors–Clinical significance and prognosis

doi: 10.1371/journal.pone.0302813

Figure Lengend Snippet: Median Toll-like receptor (TLR) staining intensity in primary small bowel neuroendocrine tumors and lymph node metastases.

Article Snippet: After this, sections were incubated with rabbit polyclonal antibodies (TLRs 1, 2, 6, 7) and mouse monoclonal antibodies (TLRs 3, 4, 5, 8, 9) in dilute solution (Dako S2022); TLR1 for 60 minutes (diluted 1:300, Abcam ab189337), TLR2 for 60 minutes (diluted 1:500, Rockland 600-401-956), TLR3 for 120 minutes (diluted 1:30, Novus NBP2-24875), TLR4 for 60 minutes (diluted 1:1000, Abnova H00007099-M02), TLR5 for overnight in +4°C (diluted 1:75, Novus NBP2-24787), TLR6 for 60 minutes (diluted 1:750, Abnova PAB 3555), TLR7 for 60 minutes (diluted 1:500, Novus NB100-56682), TLR8 for 60 minutes (diluted 1:850, Novus NBP2-24917) and TLR9 for 60 minutes (diluted 1:300, Novus NBP2-24729).

Techniques: Staining

Disease-specific survival rates based on Toll-like receptor (TLR) 1, 2, 4, 5, 6, 7, 8, and 9 cytoplasmic staining intensity and TLR5 nucleic staining intensity in both primary tumors and lymph node metastases.

Journal: PLOS ONE

Article Title: Toll-like receptors 1–9 in small bowel neuroendocrine tumors–Clinical significance and prognosis

doi: 10.1371/journal.pone.0302813

Figure Lengend Snippet: Disease-specific survival rates based on Toll-like receptor (TLR) 1, 2, 4, 5, 6, 7, 8, and 9 cytoplasmic staining intensity and TLR5 nucleic staining intensity in both primary tumors and lymph node metastases.

Article Snippet: After this, sections were incubated with rabbit polyclonal antibodies (TLRs 1, 2, 6, 7) and mouse monoclonal antibodies (TLRs 3, 4, 5, 8, 9) in dilute solution (Dako S2022); TLR1 for 60 minutes (diluted 1:300, Abcam ab189337), TLR2 for 60 minutes (diluted 1:500, Rockland 600-401-956), TLR3 for 120 minutes (diluted 1:30, Novus NBP2-24875), TLR4 for 60 minutes (diluted 1:1000, Abnova H00007099-M02), TLR5 for overnight in +4°C (diluted 1:75, Novus NBP2-24787), TLR6 for 60 minutes (diluted 1:750, Abnova PAB 3555), TLR7 for 60 minutes (diluted 1:500, Novus NB100-56682), TLR8 for 60 minutes (diluted 1:850, Novus NBP2-24917) and TLR9 for 60 minutes (diluted 1:300, Novus NBP2-24729).

Techniques: Staining

HSV and PAMPs induce IFN, ISGs, and proinflammatory cytokines in human primary macrophages. (A to C and G) Macrophages were infected with HSV-1 (17+, 5 × 105 PFU/ml, MOI of 1) or transfected with poly(I:C) [t-poly(I:C); 2 μg/ml] or poly(dA:dT) [t-poly(dA:dT); 2 μg/ml]. (A to C and G) After 6 h, after which RNA was harvested and mRNA accumulation of IFN-β, IFN-λ1, CXCL10, and TNF-α was assayed by real-time PCR. (D, E, and H) In similar experiments, cell supernatants were harvested after 20 h and assayed for the presence of TNF-α, CXCL10, and CCL3 by ELISA. (E, F, I, and K) Macrophages were infected with HSV or stimulated with IFN-α (100 IU/ml) or the agonist for TLR2 (Pam3CSK4, 100 ng/ml), TLR3 [poly(I:C), 30 μg/ml], TLR7/8 (R848, 1 μg/ml), or TLR9 (ODN2216, 2 μg/ml). After 20 h of stimulation, supernatants were collected and protein levels assayed by ELISA. (J and L) Cells were infected with HSV-1 (17+ or KOS, 5 × 105 PFU/ml, MOI of 1) or HSV-2 (MOI of 1). Supernatants were harvested at 18 h and assayed by ELISA for CXCL10 and CCL3. The real-time PCR data are depicted as relative units (RU), which is a fold change in gene expression normalized to that of the endogenous reference gene 18S rRNA and is relative to the no template control (NTC) calibrator. The results depicted are means ± standard deviations (SD) within the shown experiment. Experiments were done five times (A and B) or two times (C to L), with similar findings.

Journal: Journal of Virology

Article Title: Early Innate Recognition of Herpes Simplex Virus in Human Primary Macrophages Is Mediated via the MDA5/MAVS-Dependent and MDA5/MAVS/RNA Polymerase III-Independent Pathways

doi: 10.1128/JVI.01106-10

Figure Lengend Snippet: HSV and PAMPs induce IFN, ISGs, and proinflammatory cytokines in human primary macrophages. (A to C and G) Macrophages were infected with HSV-1 (17+, 5 × 105 PFU/ml, MOI of 1) or transfected with poly(I:C) [t-poly(I:C); 2 μg/ml] or poly(dA:dT) [t-poly(dA:dT); 2 μg/ml]. (A to C and G) After 6 h, after which RNA was harvested and mRNA accumulation of IFN-β, IFN-λ1, CXCL10, and TNF-α was assayed by real-time PCR. (D, E, and H) In similar experiments, cell supernatants were harvested after 20 h and assayed for the presence of TNF-α, CXCL10, and CCL3 by ELISA. (E, F, I, and K) Macrophages were infected with HSV or stimulated with IFN-α (100 IU/ml) or the agonist for TLR2 (Pam3CSK4, 100 ng/ml), TLR3 [poly(I:C), 30 μg/ml], TLR7/8 (R848, 1 μg/ml), or TLR9 (ODN2216, 2 μg/ml). After 20 h of stimulation, supernatants were collected and protein levels assayed by ELISA. (J and L) Cells were infected with HSV-1 (17+ or KOS, 5 × 105 PFU/ml, MOI of 1) or HSV-2 (MOI of 1). Supernatants were harvested at 18 h and assayed by ELISA for CXCL10 and CCL3. The real-time PCR data are depicted as relative units (RU), which is a fold change in gene expression normalized to that of the endogenous reference gene 18S rRNA and is relative to the no template control (NTC) calibrator. The results depicted are means ± standard deviations (SD) within the shown experiment. Experiments were done five times (A and B) or two times (C to L), with similar findings.

Article Snippet: Anti-human TLR2 neutralizing antibodies (ImmunoKontact and Imgenex) were added at a final concentration of 8.5 μg/ml 30 min prior to virus stimulation.

Techniques: Infection, Transfection, Real-time Polymerase Chain Reaction, Enzyme-linked Immunosorbent Assay, Expressing

HSV-1 infection activates cytokine expression independently of TLR2. Cells were infected with HSV-1 (17+, MOI of 1) or stimulated with TLR2 ligand Pam3CSK4 (100 ng/ml) in the presence or absence of TLR2 neutralizing antibodies (8.5 μg/ml). After 6 h, RNA was harvested, and after 18 h, supernatants were collected. Accumulation of TNF-α and IFN-β mRNA was assessed by real-time PCR (B and C), and the amounts of secreted TNF-α, CXCL10, and CCL3 were measured by ELISA (A, D, and E). RU, relative units. The results depicted are means ± SD from one of two experiments showing similar results.

Journal: Journal of Virology

Article Title: Early Innate Recognition of Herpes Simplex Virus in Human Primary Macrophages Is Mediated via the MDA5/MAVS-Dependent and MDA5/MAVS/RNA Polymerase III-Independent Pathways

doi: 10.1128/JVI.01106-10

Figure Lengend Snippet: HSV-1 infection activates cytokine expression independently of TLR2. Cells were infected with HSV-1 (17+, MOI of 1) or stimulated with TLR2 ligand Pam3CSK4 (100 ng/ml) in the presence or absence of TLR2 neutralizing antibodies (8.5 μg/ml). After 6 h, RNA was harvested, and after 18 h, supernatants were collected. Accumulation of TNF-α and IFN-β mRNA was assessed by real-time PCR (B and C), and the amounts of secreted TNF-α, CXCL10, and CCL3 were measured by ELISA (A, D, and E). RU, relative units. The results depicted are means ± SD from one of two experiments showing similar results.

Article Snippet: Anti-human TLR2 neutralizing antibodies (ImmunoKontact and Imgenex) were added at a final concentration of 8.5 μg/ml 30 min prior to virus stimulation.

Techniques: Infection, Expressing, Real-time Polymerase Chain Reaction, Enzyme-linked Immunosorbent Assay